Since 1981, Medicomp has been advancing the science of cardiac monitoring, with industry-leading innovations for the medical community.
Medicomp earned The Joint Commission’s Gold Seal of Approval for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally recognized standards. The Gold Seal of Approval is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.
Medicomp makes another technological leap with the introduction of TelePatch
™, a first-of-its-kind patch style monitor completely free of wires and cables and with the highest clinical yield in the industry.
TelePatch breaks the mold with a small, band-aid style form factor, seven-day patch and battery life, water resistance, multiple wear options and single- or dual-channel configurations.
Medicomp introduces its first dual monitoring device, the Duet 2-in-1 Monitor. It offers Mobile Cardiac Telemetry and Wireless Event cardiac monitoring in one ambulatory monitor.
Medicomp introduces SAVI Air, the first and only Wireless Event Monitor to offer beat-to-beat analysis of the entire ECG, a patented feature previously unavailable to healthcare.
We celebrate our Independence Day annually on April 1. It was on this day in 2011 that Medicomp became an independent company, separating from the parent company, United Therapeutics, that mentored and incubated us.
Launched SAVI Wireless, the first mobile cardiac telemetry (MCT) system capable of analyzing rate, rhythm, morphology, and p-wave abnormalities.
Medicomp’s Arrhythmia Access™ iPhone app is approved by Apple and launched on the app store, allowing physicians to view cardiac reports on their iPhone or iPod touch.
Medicomp is awarded the cardiac monitoring contract for the multinational CABANA clinical trial, researching atrial fibrillation.
Introduced industry first AF Burden statistical package on an intelligent event monitor.
Introduction of patented finger electrode adapter, which allows patients to conveniently take real-time event strips using their finger tips.
CardioPAL SAVI is the first Event Monitor with p-wave analysis for the detection of atrial arrhythmias.
The launch of the CardioPAL artificial intelligence introduces the first event monitor with a full-fledged Holter algorithm on-board to auto capture based on rate, rhythm and morphology.
NASA chooses Medicomp to provide Holter monitors for use on the International Space Station.
Medicomp’s CardioPAL introduced as the first event monitor capable of both real-time and continuous looping ECG monitoring.
Medicomp opens its first Cardiac Monitoring Center (CMC) — an independent diagnostic testing facility — to deliver Holter monitoring services nationwide over normal telephone lines, with guaranteed 24-hour turnaround time. Later, Medicomp would open three more CMCs around the country to handle Holter, Event and Mobile Cardiac Telemetry services around the world.
Medicomp designed and installed the first large scale point-to-point digital Holter network, across 27 locations, resulting in significant time and cost savings over traditional routing methods.
Medicomp provide Holter Monitoring for the Mir Space Station becoming the first Holter in outer space.
Epicardia 4000 is the company’s flagship product, designed for large hospitals and medical centers. Both systems provide ST segment analysis, heart rate variability and pacemaker detection, and continue to evolve with the latest technologies.
Medicomp receives patent for the Diogenes algorithm, an artificial intelligence ECG algorithm capable of analyzing rate, rhythm, and morphology.
Through the use of innovative data compression techniques, Medicomp introduced the first system capable of storing 24 entire hours of ECG data in solid-state memory.
Medicomp introduced the first solid-state, arrhythmia analysis for ambulatory patient monitoring. This Holter device also incorporated automatic selection and storage of two-channel ECG strips (normal and abnormal).
Founded in 1981